154.40
price up icon1.76%   2.67
after-market Dopo l'orario di chiusura: 154.40
loading
Precedente Chiudi:
$151.73
Aprire:
$151
Volume 24 ore:
1.01M
Relative Volume:
0.66
Capitalizzazione di mercato:
$7.42B
Reddito:
$4.06B
Utile/perdita netta:
$413.08M
Rapporto P/E:
19.28
EPS:
8.01
Flusso di cassa netto:
$560.48M
1 W Prestazione:
+4.04%
1M Prestazione:
+13.84%
6M Prestazione:
-16.36%
1 anno Prestazione:
-24.03%
Intervallo 1D:
Value
$150.35
$160.40
Intervallo di 1 settimana:
Value
$146.00
$160.40
Portata 52W:
Value
$91.86
$254.15

Charles River Laboratories International Inc Stock (CRL) Company Profile

Name
Nome
Charles River Laboratories International Inc
Name
Telefono
781-222-6000
Name
Indirizzo
251 BALLARDVALE ST, WILMINGTON, MA
Name
Dipendente
20,100
Name
Cinguettio
@criverlabs
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
CRL's Discussions on Twitter

Confronta CRL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
CRL
Charles River Laboratories International Inc
154.40 7.42B 4.06B 413.08M 560.48M 8.01
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
421.47 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
201.10 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
542.65 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.45 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
162.61 27.64B 15.50B 1.33B 2.16B 7.34

Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-23 Aggiornamento Redburn Atlantic Neutral → Buy
2025-05-14 Aggiornamento TD Cowen Hold → Buy
2025-05-08 Aggiornamento Evercore ISI In-line → Outperform
2025-03-21 Downgrade Goldman Buy → Neutral
2025-03-04 Aggiornamento Citigroup Sell → Neutral
2025-03-03 Aggiornamento Redburn Atlantic Sell → Neutral
2025-01-22 Downgrade William Blair Outperform → Mkt Perform
2025-01-17 Downgrade UBS Buy → Neutral
2024-11-18 Downgrade CLSA Hold → Underperform
2024-11-07 Aggiornamento CLSA Underperform → Hold
2024-10-23 Iniziato CLSA Underperform
2024-10-14 Iniziato Redburn Atlantic Sell
2024-10-07 Downgrade Evercore ISI Outperform → In-line
2024-10-02 Downgrade BofA Securities Buy → Neutral
2024-10-01 Downgrade Citigroup Neutral → Sell
2024-08-08 Downgrade JP Morgan Overweight → Neutral
2024-08-08 Downgrade Robert W. Baird Outperform → Neutral
2024-06-28 Downgrade Argus Buy → Hold
2024-06-07 Iniziato Mizuho Neutral
2024-06-06 Iniziato Goldman Buy
2024-02-15 Downgrade Guggenheim Buy → Neutral
2023-09-13 Iniziato TD Cowen Market Perform
2023-07-10 Downgrade Citigroup Buy → Neutral
2023-02-23 Aggiornamento Guggenheim Neutral → Buy
2023-01-12 Downgrade Jefferies Buy → Hold
2022-09-30 Aggiornamento Jefferies Hold → Buy
2022-08-25 Iniziato Credit Suisse Outperform
2022-08-04 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-05-24 Iniziato Guggenheim Neutral
2022-04-25 Downgrade Jefferies Buy → Hold
2022-04-07 Iniziato Stephens Overweight
2022-02-17 Reiterato BofA Securities Buy
2022-02-17 Aggiornamento Citigroup Neutral → Buy
2022-02-17 Reiterato Deutsche Bank Buy
2022-02-17 Reiterato Morgan Stanley Overweight
2022-02-17 Reiterato UBS Buy
2021-08-05 Ripresa Credit Suisse Neutral
2020-12-16 Downgrade Citigroup Buy → Neutral
2020-09-10 Aggiornamento Jefferies Hold → Buy
2020-07-01 Aggiornamento BofA Securities Neutral → Buy
2020-05-13 Aggiornamento UBS Neutral → Buy
2020-04-21 Downgrade Jefferies Buy → Hold
2020-03-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-03-02 Iniziato Deutsche Bank Buy
2020-02-18 Aggiornamento Wolfe Research Peer Perform → Outperform
2020-01-10 Aggiornamento Goldman Neutral → Buy
2020-01-08 Iniziato Wells Fargo Overweight
2020-01-07 Iniziato Citigroup Buy
2019-10-18 Downgrade BofA/Merrill Buy → Neutral
2019-06-10 Iniziato SVB Leerink Outperform
2019-04-30 Ripresa Evercore ISI Outperform
2018-12-14 Iniziato Deutsche Bank Buy
2018-10-09 Iniziato UBS Neutral
2018-08-23 Aggiornamento Raymond James Mkt Perform → Outperform
2018-07-17 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2018-06-15 Aggiornamento KeyBanc Capital Mkts Sector Weight → Overweight
2018-02-14 Aggiornamento SunTrust Hold → Buy
Mostra tutto

Charles River Laboratories International Inc Borsa (CRL) Ultime notizie

pulisher
Jun 17, 2025

Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 17, 2025
pulisher
Jun 16, 2025

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment | CRL Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment - Business Wire

Jun 16, 2025
pulisher
Jun 16, 2025

Do Wall Street Analysts Like Charles River Laboratories Stock? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

Global Viral Inactivation Market | Solvent Detergent & - openPR.com

Jun 16, 2025
pulisher
Jun 14, 2025

Charles River falls after projecting 2025 revenue drop - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Medical Device Testing Market Trends | Regulatory Compliance - openPR.com

Jun 13, 2025
pulisher
Jun 13, 2025

Charles River Laboratories credit outlook lowered to stable at S&P on weak 2025 guidance - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call Transcript - MSN

Jun 13, 2025
pulisher
Jun 12, 2025

Charles River surges after Q1 beat, guidance raise - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

FDA’s Intent To Phase Out Animal Testing Requirement Weighs Down Charles River Stock: Retail’s Disheartened - MSN

Jun 12, 2025
pulisher
Jun 11, 2025

Insiders At Charles River Laboratories International Sold US$2.8m In Stock, Alluding To Potential Weakness - simplywall.st

Jun 11, 2025
pulisher
Jun 11, 2025

Rhumbline Advisers Increases Stake in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Jun 11, 2025
pulisher
Jun 09, 2025

Transcript : Charles River Laboratories International, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Polen U.S SMID Company Growth Strategy Sold Charles River Laboratories International (CRL) for More Attractive Opportunities - Insider Monkey

Jun 09, 2025
pulisher
Jun 06, 2025

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.

Jun 05, 2025
pulisher
Jun 04, 2025

William Blair Remains a Hold on Charles River Labs (CRL) - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Charles River at Jefferies Conference: Strategic Moves Amid Challenges By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Transcript : Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10 - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Charles River Laboratories To Present At Jefferies Global Conference; Webcast At 10:30 AM ET - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

Cell Banking Outsourcing Market To Witness Substantial Growth, - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Charles River Stock May Gain From Extended CHDI Research Deal on HD - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

Charles River Laboratories International Inc (CRL) Shares Up 3.0 - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Charles River at William Blair Conference: Navigating Challenges with Innovation - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Charles River Laboratories To Present At William Blair Growth Stock Conference; Webcast At 11:00 AM - Nasdaq

Jun 03, 2025
pulisher
Jun 02, 2025

Charles River Laboratories to Present at William Blair and Jefferies Conferences - BioSpace

Jun 02, 2025
pulisher
Jun 02, 2025

Charles River Laboratories to Present at William Blair and Jeffe - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Charles River Laboratories to Present at William Blair and Jefferies Conferences | CRL Stock News - GuruFocus

Jun 02, 2025
pulisher
May 30, 2025

Charles River Laboratories International, Inc. (CRL): A Bull Case Theory - Insider Monkey

May 30, 2025
pulisher
May 28, 2025

Charles River Laboratories, CHDI Foundation Extend Collaboration - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research - BioSpace

May 28, 2025
pulisher
May 28, 2025

Charles River Laboratories International Extend Drug Discovery Partnership With CHDI Foundation - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Charles River Labs extends Huntington’s disease research pact By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Charles River (CRL) and CHDI Foundation Extend Partnership for H - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Charles River Labs extends Huntington’s disease research pact - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Charles River (CRL) and CHDI Foundation Extend Partnership for Huntington's Drug Discovery | CRL Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Charles River Laboratories (CRL) and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research - StreetInsider

May 28, 2025
pulisher
May 25, 2025

Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT - MSN

May 25, 2025
pulisher
May 25, 2025

Should You Continue to Hold Charles River Stock in Your Portfolio? - MSN

May 25, 2025
pulisher
May 24, 2025

There's No Escaping Charles River Laboratories International, Inc.'s (NYSE:CRL) Muted Revenues Despite A 25% Share Price Rise - simplywall.st

May 24, 2025
pulisher
May 23, 2025

Charles River Laboratories International, Inc. (CRL) Extends CEO's Employment Agreement - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Charles River (CRL) Upgraded to Buy Amid Strategic Developments | CRL Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Redburn raises Charles River Labs to buy, cuts price target to $182 - Investing.com Nigeria

May 23, 2025
pulisher
May 23, 2025

Redburn raises Charles River Labs to buy, cuts price target to $182 By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 23, 2025

Charles River Laboratories International CEO James C. Foster's Employment Extended Until February 2027SEC Filing - marketscreener.com

May 23, 2025

Charles River Laboratories International Inc Azioni (CRL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Charles River Laboratories International Inc Azioni (CRL) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
MASSARO GEORGE
Director
May 15 '25
Sale
137.57
140
19,260
5,575
MASSARO GEORGE
Director
May 14 '25
Sale
140.73
140
19,703
5,715
LaPlume Joseph W
EVP, Corp Strategy & Develop
May 13 '25
Sale
145.41
500
72,705
19,513
diagnostics_research DGX
$179.33
price down icon 0.17%
diagnostics_research WAT
$357.04
price up icon 2.29%
diagnostics_research LH
$264.26
price up icon 0.67%
$160.72
price down icon 4.87%
diagnostics_research MTD
$1,205.29
price up icon 2.60%
diagnostics_research IQV
$162.61
price up icon 3.19%
Capitalizzazione:     |  Volume (24 ore):